Cambium Biotech Private Limited

This company processes and packages a variety of mushrooms and other agricultural products.

2011 | Mumbai, Maharashtra (India) | Active
Last Updated:

Cambium Biotech Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.45 Cr
  • Company Age 13 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 11.55 Cr
  • Revenue Growth 40.08%
  • Profit Growth 853.61%
  • Ebitda 49.42%
  • Net Worth 100.47%
  • Total Assets 87.55%

About Cambium Biotech

Cambium Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2011 and has a history of 13 years and ten months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Food And Beverages Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.45 Cr.

The company has closed loans amounting to ₹11.55 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Jha Neelkamal, Ambrish Kashyap, and Naresh Kedia serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U15400MH2011PTC216776

  • Company No.

    216776

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Apr 2011

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Food and Beverages
Company report

Cambium Biotech Private Limited

Explore comprehensive data for Cambium Biotech Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Cambium Biotech?

Board Members (3)

NameDesignationAppointment DateStatus
Jha Neelkamal Country flag representing In Director 27-Apr-2011Current
Ambrish Kashyap Country flag representing In Director 28-May-2011Current
Naresh Kedia Country flag representing In Additional Director 30-Jul-2022Current

Financial Performance of Cambium Biotech.

Cambium Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.08% increase. The company also saw a substantial improvement in profitability, with a 853.61% increase in profit. The company's net worth Soared by an impressive increase of 100.47%.

Cambium Biotech revenue growth over time
Cambium Biotech profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
40.08%
Revenue from Operations
7.72%
Total Assets
87.55%
Profit or Loss
853.61%
Net Worth
100.47%
EBITDA
49.42%

What is the Ownership and Shareholding Structure of Cambium Biotech?

In 2023, Cambium Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹11.55 Cr

Charges Breakdown by Lending Institutions

  • Uco Bank : 11.55 Cr

Latest Charge Details

DateLenderAmountStatus
05 Jan 2012Uco Bank₹11.55 CrSatisfied

How Many Employees Work at Cambium Biotech?

Unlock and access historical data on people associated with Cambium Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Cambium Biotech Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cambium Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cambium Biotech's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cambium Biotech

Recent activity within the organization

  • Annual General Meeting

    Cambium Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Cambium Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Naresh Ramniwas Kedia was appointed as a Additional Director was appointed as a Additional Director on 30 Jul 2022 & has been associated with this company since 2 years 7 months .

  • Charges

    A charge registered on 05 Jan 2012 via Charge ID 10334816 with Uco Bank was fully satisfied on 27 Jul 2022.

  • Charges

    A charge with Uco Bank of Rs. 11.55 Cr registered on 05 Jan 2012 with Charge ID 10334816 was modified on 12 Aug 2016.

  • Charges

    A charge with Uco Bank amounted to Rs. 11.55 Cr with Charge ID 10334816 was registered on 05 Jan 2012.

Frequently asked questions

  • What is the Incorporation or founding date of Cambium Biotech Private Limited?

    Cambium Biotech Private Limited was incorporated on 27 Apr 2011.

  • What is authorized share capital and paid-up capital of Cambium Biotech Private Limited?

    The authorized share capital of Cambium Biotech Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.45 Cr.

  • Who are the current board members & directors of Cambium Biotech Private Limited?

    Currently 3 directors are associated with Cambium Biotech Private Limited.

    • Jha Amarnath Neelkamal
    • Ambrish Kashyap
    • Naresh Ramniwas Kedia
  • What is the registered address of Cambium Biotech Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cambium Biotech Private Limited is Flat No.712 C-Wing Bldg No.2 Dheeraj Valley Sai Baba Complex, Goregaon (East) India, Mumbai, Maharashtra, 400063.

  • What is the corporate identification number (CIN) and company number of Cambium Biotech Private Limited?

    The corporate identification number (CIN) of Cambium Biotech Private Limited is U15400MH2011PTC216776 and the company number is 216776 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Cambium Biotech Private Limited?

    The Official website of Cambium Biotech Private Limited is https://www.cambiumbiotech.com

  • What has been the recent revenue trend for Cambium Biotech Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Cambium Biotech Private Limited has risen by 40.08%.

  • What change has been observed in the net worth of Cambium Biotech Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Cambium Biotech Private Limited has experienced an upsurge of 100.47%.

  • When was the last Balance Sheet of Cambium Biotech Private Limited filed with the ROC?

    The most recent Balance Sheet for Cambium Biotech Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed